Exelixis Inc
EXEL
☕ $6/day into EXEL since 2015 would be worth $65,729 today — 3.8× the money.
Try your own number →Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Description from Wikipedia · CC BY-SA 4.0
Read more on Wikipedia →If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of EXEL would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2000) — listing | $245,848 6.2× | $357,129 6.2× |
| Year 6 (2005) | $206,159 6.4× | $299,410 6.4× |
| Year 11 (2010) | $151,918 6.1× | $220,798 6.1× |
| Year 16 (2015) | $65,729 3.8× | $95,422 3.8× |
| Year 21 (2020) | $21,398 2.2× | $31,105 2.2× |
| Year 26 (2025) | $2,681 1.3× | $3,910 1.3× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Alameda, California, United States
Popular scenarios with EXEL
For illustration only — not investment advice. Past performance is not indicative of future results.